Entrada Therapeutics Stock Price Prediction

Intrinsic Valuation Low Real High 18.24 21.56 24.89 Details

5 Analysts Consensus Low Target High 22.75 25.00 27.75 Details

Earnings Estimates (0) Low Projected EPS High 0.23 0.26 0.30 Details

Entrada Therapeutics After-Hype Price Prediction Density Analysis

Entrada Therapeutics Estimiated After-Hype Price Volatility

Entrada Therapeutics Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.30	3.32	0.17	0.05	8 Events / Month	14 Events / Month	In about 8 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
19.37	19.54	0.88	582.46   Notes

Entrada Therapeutics Hype Timeline

Entrada Therapeutics is at this time traded for 19.37. The entity has historical hype elasticity of 0.17, and average elasticity to hype of competition of 0.05. Entrada is forecasted to increase in value after the next headline, with the price projected to jump to 19.54 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.88%, whereas the daily expected return is at this time at 0.3%. The volatility of related hype on Entrada Therapeutics is about 2101.27%, with the expected price after the next announcement by competition of 19.42. The company reported the previous year's revenue of 129.01 M. Net Loss for the year was (6.68 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Entrada Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Entrada Stock refer to our How to Trade Entrada Stock guide.

Entrada Therapeutics Related Hype Analysis

Entrada Therapeutics Additional Predictive Modules

Most predictive techniques to examine Entrada price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entrada using various technical indicators. When you analyze Entrada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Entrada Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Entrada Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Entrada Therapeutics based on analysis of Entrada Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Entrada Therapeutics depends on current market conditions and Entrada Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Entrada Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Entrada Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Entrada Therapeutics' future price predictability will typically decrease when Entrada Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Entrada Therapeutics often depends not only on the future outlook of the potential Entrada Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entrada Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.